Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
Analysis of the 2018-19 Australian Federal Budget: significant reforms for corporates, small business and personal tax.
King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.
We explore how international arbitration has adapted and will continue to adapt in 2018 to global challenges and opportunities.
King & Wood Mallesons’ cross-border team advised Weichai Power ("Weichai") one of China’s leading automobile and equipment manufacturing companies.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the rights to Seroquel...
These representations earned the Kyrgyz Republic a win in an investment treaty interpretation case named by Global Arbitration Review as among the ten 'most important decisions' of 2014 globally.
King & Wood Mallesons represented NextView Capital, a leading Chinese institutional fund management group focused on new technologies and energy in its acquisition of a 19.89% equity interest in...